前列地尔联合清胰汤治疗急性胰腺炎并局限性腹膜炎的临床价值  

Clinical Effect of Qianliedier Combined with Qingyi Soup in the Treatment of Acute Pancreatitis and Limited Peritonitis

作　　者：汤枫 谭洪育 雍铁山 

机构地区：[1]江西省萍乡市湘雅萍矿合作医院普外科,江西萍乡337000

出　　处：《药品评价》2016年第17期47-49,共3页Drug Evaluation

摘　　要：目的:探讨急性胰腺炎合并局限性腹膜炎患者采用前列地尔与清胰汤治疗的临床效果。方法:随机抽取2011年1月至2016年1月江西省萍乡市湘雅萍矿合作医院收治的116例急性胰腺炎合并局限性腹膜炎患者,所有患者均经临床检查,确诊为急性胰腺炎合并局限性腹膜炎,并知情同意。将116例患者按照随机数字表法分为A(常规治疗,n=29)、B(单纯前列地尔,n=29)、C(单纯清胰汤,n=29)、D(前列地尔+清胰汤,n=29)四组。对比四组患者的治疗效果。结果:D组患者症状消失时间、血淀粉酶恢复正常时间均优于A组、B组、C组,结果有显著性差异(P<0.05);四组患者假性囊肿发生率、转外科手术率对比,结果无显著性差异(P>0.05);D组不良反应发生率明显低于A组、B组、C组,结果有显著性差异(P<0.05)。结论:急性胰腺炎合并局限性腹膜炎患者采用前列地尔与清胰汤联合治疗,能获得较好的临床效果,安全可靠,值得进行深入研究和推广。Objective： To study the Clinical effect of Qianliedier combined with Qingyi soup in the treatment of acute pancreatitis and limited peritonitis. Methods： 116 cases of acute pancreatitis with limited peritonitis patients from January 2011-January 2016 in our hospital were randomly selected and divided into A （regular treatment, n=29） and B （Qianliedier, n=29）, C （Qingyi soup, n=29）, D （Qianliedier＋Qingyi soup, n=29）. The therapeutic effect of four groups of patients was compared. Remllts： The symptoms disappear time, blood amylase returned to normal time of group D are better than that of group A, group B and group C （P〈0.05）; there was no significant difference in the incidence of pseudocyst, surgical rate between the four groups （P〉0.05）; adverse reactions incidence of Group D was lower than that in group A, group B and group C （P〈0.05）. Conclusion： Patients with acute pancreatifis and limited peritonitis with Qianliedier and Qingyi soup combined treatment obtained good clinical effect. It is safe and reliable, thus worth further research and promotion.

关 键 词：急性胰腺炎 局限性腹膜炎 前列地尔 清胰汤 

分 类 号：R576[医药卫生—消化系统] R572.2[医药卫生—内科学]